Faeth Therapeutics, Inc. - Common Stock (FTH)
12.92
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 11th, 9:11 AM EST
US Session Top Movers: FISN, XHLD, TLS Lead Gainers; ZURA, SOC, PLCE Lead Loserschartmill.com
Via Chartmill · November 9, 2026
Top Movers Today: MF Gains 89.56%, ZURA Falls 72.98%chartmill.com
Via Chartmill · November 9, 2026
US Gap-Up and Gap-Down Movers for the Nov. 9, 2026 Sessionchartmill.com
Via Chartmill · November 9, 2026
Premarket Movers on Nov. 9, 2026: Small-Cap Gainers and Loserschartmill.com
Via Chartmill · November 9, 2026
After-Hours Market Movers: Gainers and Decliners From Today's U.S. Sessionchartmill.com
Via Chartmill · November 6, 2026
Sensei Biotherapeutics Highlights PIKTOR Strategy Ahead of Endometrial Trial Readoutmarketbeat.com
Faeth Therapeutics outlined its clinical strategy for PIKTOR, an oral combination designed to inhibit the PI3K/AKT/mTOR, or PAM, pathway at multiple points, during an analyst and investor event. The company is developing the regimen in endometrial cancer and hormone receptor-positive, HER2-negative
Via MarketBeat · October 7, 2026